Guillaume Cartron
6Patents
3h-index
10Co-inventors
50Inventor score
Filing activity: Oct 11, 2002 → Jun 27, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9492562B2 | Targeted human-interferon fusion proteins | Chemistry; Metallurgy | 14 | Active |
| US9878014B2 | Targeted human-interferon fusion proteins | Chemistry; Metallurgy | 14 | Active |
| US10034919B2 | Targeted human-interferon fusion proteins | Chemistry; Metallurgy | 13 | Active |
| US10946070B2 | Targeted and mutated human-interferon fusion proteins | Chemistry; Metallurgy | 3 | Active |
| US10676791B2 | Methods for predicting response to DNA repair pathway inhibitors in diffuse large B-cell lymphoma | Physics | 2 | Active |
| US7858300B2 | Methods and compositions to evaluate antibody treatment response | Chemistry; Metallurgy | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.